Filing Flows › Northwest Biotherapeutics (NWBO) › Stock forecast & fair value
Northwest Biotherapeutics (NWBO) stock forecast and price target
Northwest Biotherapeutics (NWBO) trades at $0.17. One analyst's price target is $1.00 (+488%).
Price$0.17
Median target$1.00
Northwest Biotherapeutics' latest quarter
Northwest Biotherapeutics, Q2 2026: revenue $807K (+516% year over year), net loss $15.4M, operating cash flow −$7.2M. The chart follows the revenue to costs, profit and cash.
Questions
What is the price target for NWBO stock?
One analyst's 12-month target is $1.00, +488% from $0.17. The average rating is none.
Is NWBO stock a buy?
Filing Flows does not give advice. It shows what analysts expect, what each valuation method implies and the figures behind them, read from SEC filings, so you can judge for yourself.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.